Globus Medical Inc 's (GMED) Outlook - CSIMarket
CSIMarket
 
Globus Medical Inc   (NYSE: GMED)
 



  Globus Medical Inc Outlook

On January 10 2024 the Globus Medical Inc provided following guidance

Globus Medical, Inc., a renowned company in musculoskeletal solutions, has recently disclosed its preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2023. The company forecasts fourth quarter 2023 sales of approximately $615.5 million, reflecting a remarkable surge of 124.2 percent compared to the fourth quarter of 2022. Moreover, the full-year sales for 2023 are projected to reach around $1.567 billion, showcasing a substantial growth of 53.2 percent in comparison to the previous year. These estimations indicate a hugely successful year for Globus Medical, affirming its strong position in the market.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.